Blog

FDA Updates ICH E14 Q&A Modelling in QTc Prolongation Studies

juillet 14, 2017

Greg Hileman, Ph.D., Sr. Director and Principle Regulatory Scientist The International Conference on Harmonization (ICH) last updated its guidance “THE...

Read More
Blog

Compassionate Use: providing cancer care outside trials

mai 2, 2017

Being a challenging and arduous operation, finding new therapies to treat cancer often is a time-consuming process. For some patients, marketed...

Read More
Blog

CANCER IMMUNOTHERAPY: A NEW HOPE

mars 23, 2017

By Reshma Jagasia, Ph.D, Scientist at Cato Research The current standard of care for cancer treatment is surgery, chemotherapy, and...

Read More
Blog

A New Expedited Review Designation: Regenerative Advanced Therapy

février 9, 2017

By Michelle Villasmil, Ph.D., RAC (U.S.), Regulatory Scientist One of the many changes brought by the 21st Century Cures Act...

Read More
Blog

Transparency Initiatives at Health Canada

janvier 4, 2017

By Amelie Rodrigue-Way, Ph.D., RAC (CAN), Associate Director, Regulatory Strategy. As part of the Regulatory Transparency and Openness Framework (http://www.hc-sc.gc.ca/home-accueil/rto-tor/index-eng.php),...

Read More